Analyst Consensus ?
ConsensusBuy50 ratings
Bullish3570.0%
Neutral1224.0%
Bearish36.0%
FN2 Earnings Intelligence
Insulet Corp. complete analyst coverage
Insulet Corp. (PODD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$166.5Current
$174Low
$266.7Average
$450High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Jul 13, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 10, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| BTIG | Buy | Buy | Maintain | May 27, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 18, 2026 |
| Barclays | Underweight | Underweight | Maintain | May 8, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 7, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | May 7, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 7, 2026 |
| Rothschild & Co | Neutral | Buy | Downgrade | Apr 24, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 9, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Feb 19, 2026 |
| UBS | Buy | Neutral | Upgrade | Nov 19, 2025 |
| Jefferies | Buy | Buy | Maintain | Nov 6, 2025 |
| Raymond James | Outperform | Outperform | Maintain | May 27, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | May 13, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 21, 2025 |
| TD Cowen | Buy | Buy | Maintain | Jan 3, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 11, 2024 |
| OTR Global | Mixed | Positive | Downgrade | Jun 10, 2024 |
| Baird | Outperform | Neutral | Upgrade | Dec 21, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | May 6, 2022 |
| CFRA | Sell | Sell | Maintain | May 8, 2020 |
| Piper Jaffray | Overweight | Overweight | Maintain | Nov 18, 2019 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Oct 3, 2019 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 3, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 6, 2019 |
| Northland Capital Markets | Market Perform | Outperform | Downgrade | Jun 10, 2019 |
| Northland | Market Perform | Outperform | Downgrade | Jun 10, 2019 |
| BTIG Research | Buy | Neutral | Upgrade | May 6, 2019 |
| Berenberg | Buy | Buy | Maintain | Apr 20, 2018 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Feb 22, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 22, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Sep 27, 2016 |
| William Blair | Outperform | Market Perform | Upgrade | Apr 29, 2016 |
| Benchmark | Buy | Hold | Upgrade | Feb 26, 2016 |
| Empire Asset Management | Sell | Sell | Maintain | Feb 25, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Aug 13, 2015 |
| Northland Securities | Outperform | Market Perform | Upgrade | May 4, 2015 |
| Leerink Swann | Outperform | Outperform | Maintain | Jan 21, 2015 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Nov 6, 2014 |
| Wedbush | Outperform | Outperform | Maintain | Oct 28, 2014 |
| Barrington Research | Outperform | Market Perform | Upgrade | May 16, 2014 |
| Feltl & Co. | Hold | Sell | Upgrade | May 8, 2014 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jun 7, 2013 |
| Wunderlich | Hold | Buy | Downgrade | Jun 7, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $166.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $174 | $165 | +4.5% | Jul 28, 2026 |
| Truist Financial | Analyst unavailable | $210 | $162.79 | +26.1% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $245 | $163.11 | +47.2% | Jul 13, 2026 |
| Stifel Nicolaus | Analyst unavailable | $225 | $158.29 | +35.1% | Jul 10, 2026 |
| Evercore ISI | Analyst unavailable | $180 | $155.44 | +8.1% | Jul 6, 2026 |
| Deutsche Bank | Analyst unavailable | $190 | $138.97 | +14.1% | Jun 23, 2026 |
| UBS | Analyst unavailable | $219 | $149.73 | +31.5% | Jun 11, 2026 |
| Truist Financial | Richard Newitter | $219 | $149.19 | +31.5% | Jun 11, 2026 |
| Raymond James | Analyst unavailable | $216 | $151.51 | +29.7% | Jun 8, 2026 |
| Goldman Sachs | David Roman | $205 | $153.8 | +23.1% | May 27, 2026 |
| BTIG | Analyst unavailable | $235 | $153.8 | +41.1% | May 26, 2026 |
| Goldman Sachs | Analyst unavailable | $237 | $160.4 | +42.3% | May 7, 2026 |
| RBC Capital | Shagun Singh | $280 | $161.1 | +68.2% | May 7, 2026 |
| Truist Financial | Richard Newitter | $250 | $157.3 | +50.2% | May 7, 2026 |
| Evercore ISI | Analyst unavailable | $200 | $156.7 | +20.1% | May 7, 2026 |
| Oppenheimer | Analyst unavailable | $210 | $151.28 | +26.1% | May 7, 2026 |
| Stifel Nicolaus | Analyst unavailable | $250 | $151.28 | +50.2% | May 7, 2026 |
| Canaccord Genuity | William Plovanic | $249 | $151.28 | +49.6% | May 7, 2026 |
| Bernstein | Analyst unavailable | $200 | $151.28 | +20.1% | May 7, 2026 |
| Barclays | Matt Miksic | $198 | $151.28 | +18.9% | May 7, 2026 |
| BTIG | Analyst unavailable | $260 | $152.67 | +56.2% | May 6, 2026 |
| Redburn Partners | Analyst unavailable | $220 | $192.21 | +32.1% | Apr 24, 2026 |
| Truist Financial | Richard Newitter | $315 | $202.28 | +89.2% | Apr 15, 2026 |
| RBC Capital | Shagun Singh | $325 | $197.81 | +95.2% | Apr 14, 2026 |
| Truist Financial | Analyst unavailable | $360 | $246.04 | +116.2% | Feb 19, 2026 |
| Evercore ISI | Analyst unavailable | $340 | $251.21 | +104.2% | Feb 19, 2026 |
| Goldman Sachs | David Roman | $326 | $251.38 | +95.8% | Feb 19, 2026 |
| Oppenheimer | Analyst unavailable | $300 | $254.59 | +80.2% | Feb 19, 2026 |
| Bernstein | Analyst unavailable | $330 | $258.07 | +98.2% | Feb 19, 2026 |
| Barclays | Analyst unavailable | $286 | $258.07 | +71.8% | Feb 19, 2026 |
| Canaccord Genuity | William Plovanic | $435 | $258.07 | +161.3% | Feb 18, 2026 |
| Stifel Nicolaus | Analyst unavailable | $350 | $249.07 | +110.2% | Feb 4, 2026 |
| Barclays | Analyst unavailable | $274 | $286.92 | +64.6% | Jan 12, 2026 |
| Bernstein | Lee Hambright | $380 | $292.89 | +128.2% | Jan 9, 2026 |
| Goldman Sachs | David Roman | $365 | $292.89 | +119.2% | Jan 9, 2026 |
| Truist Financial | Analyst unavailable | $390 | $296.42 | +134.2% | Dec 18, 2025 |
| Canaccord Genuity | Analyst unavailable | $450 | $288.73 | +170.3% | Dec 17, 2025 |
| Evercore ISI | Analyst unavailable | $370 | $295.31 | +122.2% | Dec 16, 2025 |
| Canaccord Genuity | Analyst unavailable | $432 | $331.17 | +159.5% | Nov 24, 2025 |
| Truist Financial | Richard Newitter | $412 | $325 | +147.5% | Nov 21, 2025 |
| RBC Capital | Shagun Singh | $380 | $324.2 | +128.2% | Nov 21, 2025 |
| BTIG | Analyst unavailable | $380 | $312.89 | +128.2% | Nov 21, 2025 |
| UBS | Analyst unavailable | $400 | $333.47 | +140.2% | Nov 19, 2025 |
| Jefferies | Matthew Taylor | $400 | $323.4 | +140.2% | Nov 6, 2025 |
| BTIG | Marie Thibault | $370 | $323.4 | +122.2% | Nov 6, 2025 |
| Barclays | Matt Miksic | $301 | $320.27 | +80.8% | Nov 5, 2025 |
| RBC Capital | Analyst unavailable | $365 | $318 | +119.2% | Oct 10, 2025 |
| Canaccord Genuity | Analyst unavailable | $399 | $318 | +139.6% | Sep 29, 2025 |
| Wells Fargo | Analyst unavailable | $322 | $259.52 | +93.4% | Apr 28, 2025 |
| BTIG | Marie Thibault | $270 | $268.96 | +62.2% | Nov 8, 2024 |
| Bernstein | Lee Hambright | $300 | $241.32 | +80.2% | Nov 5, 2024 |
| Raymond James | Jayson Bedford | $260 | $231.61 | +56.2% | Oct 14, 2024 |
| Piper Sandler | Matt O'Brien | $285 | $233.89 | +71.2% | Sep 17, 2024 |
| Piper Sandler | Matt O'Brien | $230 | $193.52 | +38.1% | Aug 27, 2024 |
| Oppenheimer | Steven Lichtman | $233 | $193.54 | +39.9% | Aug 27, 2024 |
| Jefferies | Matthew Taylor | $260 | $193.54 | +56.2% | Aug 27, 2024 |
| BTIG | Marie Thibault | $250 | $199.79 | +50.2% | Aug 9, 2024 |
| Barclays | Matt Miksic | $200 | $165.9 | +20.1% | May 13, 2024 |
| Wolfe Research | Mike Polark | $200 | $176.4 | +20.1% | May 7, 2024 |
| Canaccord Genuity | Kyle Rose | $226 | $166.64 | +35.7% | Mar 21, 2024 |
| Morgan Stanley | Analyst unavailable | $320 | $295 | +92.2% | Jan 6, 2023 |
| Piper Sandler | Matt O'Brien | $340 | $255.35 | +104.2% | Nov 3, 2022 |
| Morgan Stanley | Cecilia Furlong | $273 | $224.16 | +64.0% | Oct 17, 2022 |
| Raymond James | Jayson Bedford | $280 | $260.03 | +68.2% | Aug 23, 2022 |
| Bank of America Securities | Travis Steed | $300 | $265.39 | +80.2% | Mar 3, 2022 |
| UBS | Matthew Taylor | $325 | $253.19 | +95.2% | Feb 2, 2022 |
| Oppenheimer | Steven Lichtman | $275 | $248 | +65.2% | Jan 31, 2022 |
| Canaccord Genuity | Kyle Rose | $330 | $259.14 | +98.2% | Dec 6, 2021 |
| Berenberg Bank | Ravi Misra | $295 | $313.47 | +77.2% | Nov 8, 2021 |
| Citigroup | Joanne Wuensch | $350 | $308 | +110.2% | Nov 5, 2021 |
| Jefferies | Raj Denhoy | $340 | $297.51 | +104.2% | Oct 12, 2021 |
| Cowen & Co. | Josh Jennings | $310 | $271.48 | +86.2% | Jul 21, 2021 |
| Thrivent | JP McKim | $250 | $234.19 | +50.2% | May 7, 2021 |
Track every rating change on PODD the moment it posts. Free to start.
Start free